Ontology highlight
ABSTRACT: Background
The high heterogeneity of Parkinson's disease (PD) hinders personalized interventions. Brain structure reflects damage and neuroplasticity and is one of the biological bases of symptomatology. Subtyping PD in the framework of brain structure helps in the prediction of disease trajectories and optimizes treatment strategies.Methods
The study included a total of 283 de novo PD and 141 healthy controls (HC). Structural heterogeneity between PD and HC was compared, and patients were classified using Heterogeneity through Discriminative Analysis. Gray matter volume (GMV), clinical symptoms, and substantia nigra free water (SNFW) among all subtypes were compared. These subtypes were followed for an average of 2.5 years to monitor motor impairment.Results
Early
SUBMITTER: Zhou H
PROVIDER: S-EPMC11829112 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature